Ambrosiabiosciences

Our scientific team brings deep expertise across every stage of structure-based drug discovery, with contributions to 30 IND filings, 25 new molecular entities, and 7 FDA approvals.

Health and bio

Latest funding

Series B+ · March 31, 2026

Amount not disclosed in a source on record.

Funding history ↓

Website: ambrosiabiosciences.com.

X: @ambrosiabio · 7 followers.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: Biopharma, Biotechnology, Health Care.

Stage: Series B+.

Based in: Boulder, United States.

Last round: Mar 31, 2026 · 226 days ago.

On Recent Funding since: Nov 6, 2026.

Signals

X account@ambrosiabio · created Jul 25, 2024 (2 years old) · 7 followers

Website registeredFeb 12, 2024 (2 years old)

TIMELINE · MILESTONES

Ambrosiabiosciences | 778 days from website to first raise on record

@ambrosiabio·1 round·2 signals before the first raise

One step per dated milestone. Pins are dated signals; hover the icons for dates.

Funding rounds

March 31, 2026
Series B+ · amount undisclosed
Source: fundraisingfox.com
July 25, 2024
X account created
February 12, 2024
Website created

Founders and team

FN
Faraz Naqvi Founder and Medical Director

source: ambrosiabiosciences.com
KL
Kyle Lefkoff Founder and Chairman

source: ambrosiabiosciences.com
NT
Nick Traggis Founder and Chief Executive Officer

source: ambrosiabiosciences.com
LS
Linda Shapiro Manning Chief Medical Officer

Investors

Companies like Ambrosiabiosciences

DDenovo Sciences
DDandelion Health$14M Series A · May 2026
KKvantify$8.1M Seed · Mar 2026
HHotSpot Therapeutics$100M Series B+ · Nov 2021
XXFOREST Therapeutics
KKiin BioSeed · Jun 2025

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/ambrosiabiosciences (get a free API key).